Navigation Links
Elsevier Showcases Predictive Analytic and Clinical Integration Solutions at HIMSS13
Date:3/1/2013

PHILADELPHIA, March 1, 2013 /PRNewswire/ --

Dr. Peter Edelstein will discuss keys to successful clinical integration during his presentation on 'Predictive Analytics for the Bedside Provider'

Elsevier, a world-leading provider of scientific, technical and medical information products and services, will present new and enhanced analytic and clinical integration solutions at the Healthcare Information Management and Systems Society (HIMSS) annual meeting in New Orleans, March 4-6, including a new Physician Portal and expanded Physician Profiling as part of its enhanced MEDai Navigator.

In addition, Dr. Peter Edelstein , Vice President and Chief Medical Officer for Elsevier's MEDai analytics group, will discuss "Predictive Analytics for the Bedside Provider" at HIMSS13's Clinical & Business Analytics/Intelligence Knowledge Center on Monday, March 4, at 2 p.m. Elsevier also will introduce Pinpoint Risk, a predictive analytics solution that identifies and helps prevent risks to inpatients.

Elsevier's MEDai Navigator is the first payer analytics solution that goes beyond predicting and managing risks for cost savings to empower providers to improve the quality of care and patient outcomes. The new Physician Portal and Physician Profiling features have been integrated into the enhanced MEDai Navigator solution to provide a more complete, holistic approach to performance management in a common language that is meaningful and relevant to both providers and payers.  

MEDai Navigator:

  • Combines claims and clinical data into a single, clinically integrated view of the patient
  • Enables access to both patient-level analytics and performance metrics
  • Is configured to share information in real-world medical practice
  • Can be used on mobile devices (tablets and smart phones) at the point of care
  • Helps providers achieve the objectives of improving the patient experience of care, improving the health of populations, and reducing the cost of healthcare
  • Allows access to ClinicalKey, Elsevier's clinical insight engine, to provide the most current and clinically relevant evidence-based answers, expert commentary, MEDLINE abstracts and select third-party journals

"Actionable analytics not only helps payers and providers, but can significantly improve the quality and delivery of care," Edelstein said. "The new enhancements to Navigator support our continued goal of providing meaningful care to patients."

Elsevier's Pinpoint Risk is an inpatient-specific prospective risk prediction tool that stratifies and trends inpatient risks, allowing providers to intervene prior to risk realization. This real-time predictive analytics solution supports case managers, nurses and physicians using a laptop or tablet at the patient bedside. Clinical and administrative inpatient-specific data is collected automatically and electronically and then quickly analyzed along with the patient's historical data to predict risks of mortality, sepsis, transfer to ICU, excessive length of stay, and 30-day readmission.

Elsevier will demonstrate these and other clinical solutions at HIMSS13 (booth #6129) throughout the conference. For more information visit http://www.clinicaldecisionsupport.com/himss13.

# # #

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1-212-633-3164
c.capot@elsevier.com 



'/>"/>
SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elseviers MEDalternatives Offers Additional Cost Saving Options for Payers and Members
2. Elseviers Clinical Pharmacology Now Accessible Through Elsevier Infobutton
3. Elsevier Launches New Open Access Journal - Epilepsy & Behavior Case Reports
4. Elsevier and University of Surrey Sign Access Agreement to SciVal Strata
5. Elsevier and Australasian Research Management Society Announce Winners of the 2012 Scopus Young Researcher of the Year Awards
6. Elsevier Launches ClinicalKey for Individual Clinicians, Providing Comprehensive Content for 41 Specialties
7. Elsevier Acquires Atira, a Provider of Research Management Solutions
8. Elsevier Launches New Journal: Discourse, Context and Media
9. Elsevier Launches New Open Access Journal: Applied and Translational Genomics
10. Elsevier Announces New Editor-In-Chief for Neurobiology of Learning and Memory
11. Elsevier and Russias Skolkovo Foundation Sign Access Agreement to SciVerse Scopus and SciVal Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):